In this case report, we present a 45-year-old female patient who underwent emergency surgery because of right ventricular rupture during PMBV.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Percutaneous mitral balloon valvuloplasty (PMBV) is the primary treatment modality in patients with mitral stenosis without contraindications and with appropriate valve anatomy.
📊
Key Findings & Data:In the literature, the mortality rate associated with PMBV was reported to be 1%.
💡
Conclusion & Impact:In this case report, we present a 45-year-old female patient who underwent emergency surgery because of right ventricular rupture during PMBV.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Percutaneous mitral balloon valvuloplasty (PMBV) is the primary treatment modality in patients with mitral stenosis without contraindications and with appropriate valve anatomy. In the literature, the mortality rate associated with PMBV was reported to be 1%. This process may cause rare and serious complications; such as pericardial effusion, acute mitral regurgitation, cardiac tamponade, and thrombus formation. In this case report, we present a 45-year-old female patient who underwent emergency surgery because of right ventricular rupture during PMBV.
🔖
Cite This Article
SİCİM, H., DEMİRDAŞ, E., KARTAL, H., ARSLAN, G., GÜNAY, C., ÖZ, B. S. (2020). Is mitral balloon valvuloplasty really innocent?: A case report of right ventricular rupture. Gülhane Tıp Dergisi, Cilt: 62 - Sayı: 4, 278–280. https://ajindex.com/articles/226068
Kamada M, Ohsaka K, Nagamine S, Kakihata H. Mitral valve replacement after percutaneous transluminal mitral commissurotomy. Jpn J Thorac Cardiovasc Surg. 2004;52:335-338
Park SJ, Lee WK, Shim WH, Cho SY, Tahk SJ, Kim SS. Percutaneous mitral valvuloplasty using the double balloon technique: immediate results and determinant factors of increasing mitral regurgitation. Korean J Intern Med. 1991;6:51-57
Raghul G, Gopalan R, Sundram SR, Arunkumar P, Tamilarasu K, Ramasamy P. Pericardial effusion as unexpected sequelae of postmitral balloon valvuloplasty. Heart India. 2016;4:104-107
Prendergast BD, Shaw TR, Iung B, Vahanian A, Northridge DB. Contemporary criteria for the selection of patients for percutaneous balloon mitral valvuloplasty. Heart. 2002;87:401-404
Desabandhu V, Peringadan NG, Krishnan MN. Safety and efficacy of percutaneous balloon mitral valvotomy in severe mitral stenosis with moderate mitral regurgitation - A prospective study. Indian Heart J. 2016;68:783-787
Fawzy ME. Mitral balloon valvuloplasty. J Saudi Heart Assoc. 2010;22:125-132
Watanabe N. Editorial: Percutaneous mitral valvotomy: Balloon made in Japan still dominates the world. J Cardiol Cases. 2016;13:169-170.